MYNZ Stock: Mainz Biomed B.V. Stock Price, Analysis & Insights
Get live mynz stock price $1.66, comprehensive Mainz Biomed B.V. stock analysis, charts, news, and expert forecast. Real-time mynz stock data and investment insights.
Company Overview
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Company Information
- CEO
- Guido Baechler
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 19
Contact Information
- Website
- https://mainzbiomed.com
- Address
- Robert Koch Strasse 50
- Country
- DE
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 7.60M market capitalization
- Trading Volume: 32.27K shares traded today
- Price Range: 52-week range of $0.18 - $8.20
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Mainz Biomed B.V.
Mainz Biomed B.V. (MYNZ) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 7.60M, the company represents a significant player in its market. The stock is currently trading at $1.66 with a negativedaily change of 1.78%.
The company's 19 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.07, beta of 0.25, and 52-week price range from $0.18 to $8.20when evaluating investment opportunities.
Why Invest in Mainz Biomed B.V.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Guido Baechler
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.